Tectonic Therapeutic

Tectonic Therapeutic
Tectonic Therapeutic
Company Information
Company Description

Tectonic Therapeutic is a biotechnology company which studies antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs). Their proprietary GEODe™ platform targets the most difficult, previously undruggable receptors in the class, aiming to unlock their therapeutic utility to develop new treatments for a broad range of patients with important unmet needs.


Please note, it is important to assess the company’s business activities against Section 1202(e)(3) which specifies certain industries that are not considered a “qualified trade or business.”

Entity Type

Per Section 1202, entities need to be a C Corporation or equivalent in order to issue QSBS.  Refer here for further details.

Incorporation State
Qualified Small Business Stock (QSBS) Details

Exemption Level

Any individual owning stock purchased or received directly from the company could potentially be eligible for the QSBS capital gains tax exclusion or the Section 1045 gain rollover if the QSBS standards as per IRC Section 1202 were met at the time of issuance.

In order to assess whether stock issued previously may qualify, the Company would also have to have not taken actions that invalidate QSBS status such as a certain level of redemptions, and would have to satisfy the active business requirement.

Do you hold stock in this company?

Validate QSBS Eligibility
Series A Details
Series A Date
Series A Raised
Series A Lead Investors
Polaris Partners, Timothy A. Springer, Vida Ventures

This article does not constitute legal or tax advice. Please consult with your legal or tax advisor with respect to your particular circumstance.